Tumours of Haematopoietic and Lymphoid Tissues: Difference between revisions
Bailey.Glen (talk | contribs) No edit summary |
No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
==Myeloproliferative Neoplasms (MPN) ([[ | ==Myeloproliferative Neoplasms (MPN) ([[Myeloproliferative Neoplasms (MPN)|Overview Page Link]])== | ||
*[[ | *[[Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive]] | ||
*[[ | *[[Chronic Neutrophilic Leukemia (CNL)]] | ||
*[[ | *[[Polycythemia Vera (PV)]] | ||
*[[ | *[[Primary Myelofibrosis (PMF)]] | ||
*[[ | *[[Essential Thrombocythemia (ET)]] | ||
*[[ | *[[Chronic Eosinophilic Leukemia, Not Otherwise Specified]] | ||
*[[ | *[[Myeloproliferative Neoplasm (MPN), Unclassifiable]] | ||
==Mastocytosis ([[ | ==Mastocytosis ([[Mastocytosis|Overview Page Link]])== | ||
*[[ | *[[Cutaneous Mastocytosis]] | ||
*[[ | *[[Systemic Mastocytosis]] | ||
*[[ | *[[Mast Cell Sarcoma]] | ||
==Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 ([[ | ==Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 ([[Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2|Overview Page Link]])== | ||
*[[ | *[[Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement]] | ||
*[[ | *[[Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement]] | ||
*[[ | *[[Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement]] | ||
*[[ | *[[Myeloid/Lymphoid Neoplasms with PCM1-JAK2]] | ||
==Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) ([[ | ==Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) ([[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)|Overview Page Link]])== | ||
*[[ | *[[Chronic Myelomonocytic Leukemia (CMML)]] | ||
*[[ | *[[Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative]] | ||
*[[ | *[[Juvenile Myelomonocytic Leukemia (JMML)]] | ||
*[[ | *[[Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)|MDS/MPN with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)]] | ||
*[[ | *[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable|MDS/MPN, Unclassifiable]] | ||
==Myelodysplastic Syndromes (MDS) ([[ | ==Myelodysplastic Syndromes (MDS) ([[Myelodysplastic Syndromes (MDS)|Overview Page Link]])== | ||
*[[ | *[[Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia|MDS with Single Lineage Dysplasia]] | ||
*[[ | *[[Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)|MDS with Ring Sideroblasts (MDS-RS)]] | ||
*[[ | *[[Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia|MDS with Ring Sideroblasts and Multilineage Dysplasia]] | ||
*[[ | *[[Myelodysplastic Syndrome (MDS) with Multilineage Dysplasia|MDS with Multilineage Dysplasia]] | ||
*[[ | *[[Myelodysplastic Syndrome (MDS) with Excess Blasts|MDS with Excess Blasts]] | ||
*[[ | *[[Myelodysplastic Syndrome (MDS) with Isolated del(5q)|MSD with Isolated del(5q)]] | ||
*[[ | *[[Myelodysplastic Syndrome (MDS), Unclassifiable|MDS, Unclassifiable]] | ||
*[[ | *[[Refractory Cytopenia of Childhood]] | ||
==Myeloid Neoplasms with Germline Predisposition ([[ | ==Myeloid Neoplasms with Germline Predisposition ([[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Overview Page Link]])== | ||
*[[ | *[[Acute Myeloid Leukaemia with Germline CEBPA Mutation]] | ||
*[[ | *[[Myeloid Neoplasms with Germline DDX41 Mutation]] | ||
*[[ | *[[Myeloid Neoplasms with Germline RUNX1 Mutation]] | ||
*[[ | *[[Myeloid Neoplasms with Germline ANKRD26 Mutation]] | ||
*[[ | *[[Myeloid Neoplasms with Germline ETV6 Mutation]] | ||
*[[ | *[[Myeloid Neoplasms with Germline GATA2 Mutation]] | ||
==Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms ([[ | ==Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms ([[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Overview Page Link]])== | ||
*[[ | *[[Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities|AML with Recurrent Genetic Abnormalities]] | ||
- [[ | - [[Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1|AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]] | ||
- [[ | - [[Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11|AML with with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]] | ||
- [[ | - [[Acute Promyelocytic Leukemia (APL) with PML-RARA]] | ||
- [[ | - [[Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3|AML with t(9;11)(p21.3;q23.3); KMT2A-MLLT3]] | ||
- [[ | - [[Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214|AML with t(6;9)(p23;q34.1); DEK-NUP214]] | ||
- [[ | - [[Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM|AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM]] | ||
- [[ | - [[Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1|AML Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1]] | ||
- [[ | - [[Acute Myeloid Leukemia (AML) with BCR-ABL1|AML with BCR-ABL1]] | ||
- [[ | - [[Acute Myeloid Leukemia (AML) with Mutated NPM1|AML with Mutated NPM1]] | ||
- [[ | - [[Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA|AML with Biallelic Mutations of CEBPA]] | ||
- [[ | - [[Acute Myeloid Leukemia (AML) with Mutated RUNX1|AML with Mutated RUNX1]] | ||
*[[ | *[[Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes|AML with Myelodysplasia-Related Changes]] | ||
*[[ | *[[Therapy-Related Myeloid Neoplasms]] | ||
*[[ | *[[Acute Myeloid Leukemia (AML), Not Otherwise Specified|AML, Not Otherwise Specified]] | ||
- [[ | - [[Acute Myeloid Leukemia (AML) with Minimal Differentiation|AML with Minimal Differentiation]] | ||
- [[ | - [[Acute Myeloid Leukemia (AML) without Maturation|AML without Maturation]] | ||
- [[ | - [[Acute Myeloid Leukemia (AML) with Maturation|AML with Maturation]] | ||
- [[ | - [[Acute Myelomonocytic Leukemia]] | ||
- [[ | - [[Acute Monoblastic and Monocytic Leukemia]] | ||
- [[ | - [[Pure Erythroid Leukemia]] | ||
- [[ | - [[Acute Megakaryoblastic Leukemia (AMKL)]] | ||
- [[ | - [[Acute Basophilic Leukemia]] | ||
- [[ | - [[Acute Panmyelosis with Myelofibrosis]] | ||
*[[ | *[[Myeloid Sarcoma]] | ||
*[[ | *[[Myeloid Proliferations Associated with Down Syndrome]] | ||
- [[ | - [[Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome]] | ||
- [[ | - [[Myeloid Leukemia Associated with Down Syndrome]] | ||
==Blastic Plasmacytoid Dendritic Cell Neoplasm ([[ | ==Blastic Plasmacytoid Dendritic Cell Neoplasm ([[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Overview Page Link]])== | ||
*[[ | *[[Blastic Plasmacytoid Dendritic Cell Neoplasm]] | ||
==Acute Leukemias of Ambiguous Lineage (MPAL) ([[ | ==Acute Leukemias of Ambiguous Lineage (MPAL) ([[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Overview Page Link]])== | ||
*[[ | *[[Acute Leukemias of Ambiguous Lineage]] | ||
- [[ | - [[Acute Undifferentiated Leukemia]] | ||
- [[ | - [[Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1]] | ||
- [[ | - [[Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged]] | ||
- [[ | - [[Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified]] | ||
- [[ | - [[Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified]] | ||
- [[ | - [[Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types]] | ||
- [[ | - [[Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)]] | ||
==Precursor Lymphoid Neoplasms (B-ALL, T-ALL) ([[ | ==Precursor Lymphoid Neoplasms (B-ALL, T-ALL) ([[Precursor Lymphoid Neoplasms|Overview Page Link]])== | ||
*[[ | *[[B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities|B-Lymphoblastic Leukemia/Lymphoma (B-ALL) with Recurrent Genetic Abnormalities]] | ||
- [[ | - [[B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1|B-ALL with t(9;22)(q34.1;q11.2); BCR-ABL1]] | ||
- [[ | - [[B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged|B-ALL with t(v;11q23.3); KMT2A-Rearranged]] | ||
- [[ | - [[B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1|B-ALL with t(12;21)(p13.2;q22.1); ETV6-RUNX1]] | ||
- [[ | - [[B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy|B-ALL with Hyperdiploidy]] | ||
- [[ | - [[B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy|B-ALL with Hypodiploidy]] | ||
- [[ | - [[B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3|B-ALL with t(5;14)(q31.1;q32.1); IGH/IL3]] | ||
- [[ | - [[B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1|B-ALL with t(1;19)(q23;p13.3); TCF3-PBX1]] | ||
- [[ | - [[B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like|B-ALL, BCR-ABL1-Like]] | ||
- [[ | - [[B-Lymphoblastic Leukemia/Lymphoma with iAMP21|B-ALL with iAMP21]] | ||
- [[ | - [[B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified|B-ALL, Not Otherwise Specified]] | ||
*[[ | *[[T-Lymphoblastic Leukemia/Lymphoma|T-Lymphoblastic Leukemia/Lymphoma (T-ALL)]] | ||
- [[ | - [[Early T-Cell Precursor Lymphoblastic Leukemia]] | ||
- [[ | - [[NK-Lymphoblastic Leukemia/Lymphoma]] | ||
==Mature B-Cell Neoplasms (CLL, Plasma Cell Neoplasms, Non-Hodgkin B-cell Lymphomas) ([[ | ==Mature B-Cell Neoplasms (CLL, Plasma Cell Neoplasms, Non-Hodgkin B-cell Lymphomas) ([[Mature B-Cell Neoplasms|Overview Page Link]])== | ||
*[[ | *[[Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma]] | ||
- [[ | - [[Monoclonal B-cell Lymphocytosis]] | ||
*[[ | *[[B-cell Prolymphocytic Leukemia]] | ||
*[[ | *[[Splenic Marginal Zone Lymphoma]] | ||
*[[ | *[[Hairy Cell Leukemia]] | ||
*[[ | *[[Splenic B-cell Lymphoma/Leukemia, Unclassifiable]] | ||
- [[ | - [[Splenic Diffuse Red Pulp Small B-cell Lymphoma]] | ||
- [[ | - [[Hairy Cell Leukemia Variant]] | ||
*[[ | *[[Lymphoplasmacytic Lymphoma]] | ||
- [[ | - [[Waldenstrom Macroglobulinemia]] | ||
*[[ | *[[IgM Monoclonal Gammopathy of Undetermined Significance]] | ||
*[[ | *[[Heavy Chain Diseases]] | ||
- [[ | - [[Mu Heavy Chain Disease]] | ||
- [[ | - [[Gamma Heavy Chain Disease]] | ||
- [[ | - [[Alpha Heavy Chain Disease]] | ||
*[[ | *[[Plasma Cell Neoplasms]] | ||
- [[ | - [[Non-IgM Monoclonal Gammopathy of Undetermined Significance]] | ||
- [[ | - [[Plasma Cell Myeloma]] | ||
- [[ | - [[Plasma Cell Myeloma Variants]] | ||
- [[ | - [[Plasmacytoma]] | ||
- [[ | - [[Monoclonal Immunoglobulin Deposition Diseases]] | ||
- [[ | - [[Primary Amyloidosis]] | ||
- [[ | - [[Light Chain and Heavy Chain Deposition Disease]] | ||
- [[ | - [[Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome]] | ||
- [[ | - [[POEMS Syndrome]] | ||
- [[ | - [[TEMPI Syndrome]] | ||
*[[ | *[[Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)]] | ||
*[[ | *[[Nodal Marginal Zone Lymphoma]] | ||
- [[ | - [[Paediatric Nodal Marginal Zone Lymphoma]] | ||
*[[ | *[[Follicular Lymphoma]] | ||
- [[ | - [[Testicular Follicular Lymphoma]] | ||
- [[ | - [[In Situ Follicular Neoplasia]] | ||
- [[ | - [[Duodenal-Type Follicular Lymphoma]] | ||
*[[ | *[[Paediatric-Type Follicular Lymphoma]] | ||
*[[ | *[[Large B-cell Lymphoma with IRF4 Rearrangement]] | ||
*[[ | *[[Primary Cutaneous Follicle Centre Lymphoma]] | ||
*[[ | *[[Mantle Cell Lymphoma]] | ||
- [[ | - [[Leukemic Non-Nodal Mantle Cell Lymphoma]] | ||
- [[ | - [[In Situ Mantle Cell Neoplasia]] | ||
*[[ | *[[Diffuse Large B-cell Lymphoma, Not Otherwise Specified]] | ||
*[[ | *[[T-cell/Histiocyte-Rich Large B-cell Lymphoma]] | ||
*[[ | *[[Primary Diffuse Large B-cell Lymphoma of the CNS]] | ||
*[[ | *[[Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type]] | ||
*[[ | *[[EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)]] | ||
*[[ | *[[EBV-Positive Mucocutaneous Ulcer]] | ||
*[[ | *[[Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation]] | ||
- [[ | - [[Fibrin-Associated Diffuse Large B-cell Lymphoma]] | ||
*[[ | *[[Lymphomatoid Granulomatosis]] | ||
*[[ | *[[Primary Mediastinal (Thymic) Large B-cell Lymphoma]] | ||
*[[ | *[[Intravascular Large B-cell Lymphoma]] | ||
*[[ | *[[ALK-Positive Large B-cell Lymphoma]] | ||
*[[ | *[[Plasmablastic Lymphoma]] | ||
*[[ | *[[Primary Effusion Lymphoma]] | ||
*[[ | *[[HHV8-Associated Lymphoproliferative Disorders]] | ||
- [[ | - [[Multicentric Castleman Disease]] | ||
- [[ | - [[HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)]] | ||
- [[ | - [[HHV8-Positive Germinotropic Lymphoproliferative Disorder]] | ||
*[[ | *[[Burkitt Lymphoma]] | ||
*[[ | *[[Burkitt-Like Lymphoma with 11q Aberration]] | ||
*[[ | *[[High-Grade B-cell Lymphoma]] | ||
- [[ | - [[High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements]] | ||
- [[ | - [[High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)]] | ||
*[[ | *[[B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma]] | ||
==Mature T- and NK-cell Neoplasms ([[ | ==Mature T- and NK-cell Neoplasms ([[Mature T- and NK-cell Neoplasms|Overview Page Link]])== | ||
*[[ | *[[T-cell Prolymphocytic Leukemia]] | ||
*[[ | *[[T-cell Large Granular Lymphocytic Leukemia]] | ||
*[[ | *[[Chronic Lymphoproliferative Disorder of NK Cells]] | ||
*[[ | *[[Aggressive NK-cell Leukemia]] | ||
*[[ | *[[EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood]] | ||
- [[ | - [[Systemic EBV-Positive T-cell Lymphoma of Childhood]] | ||
- [[ | - [[Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form]] | ||
- [[ | - [[Hydroa Vacciniforme-Like Lymphoproliferative Disorder]] | ||
- [[ | - [[Severe Mosquito Bite Allergy]] | ||
*[[ | *[[Adult T-cell Leukemia/Lymphoma]] | ||
*[[ | *[[Extranodal NK/T-cell Lymphoma, Nasal Type]] | ||
*[[ | *[[Intestinal T-cell Lymphoma]] | ||
- [[ | - [[Enteropathy-Associated T-cell Lymphoma]] | ||
- [[ | - [[Monomorphic Epitheliotropic Intestinal T-cell Lymphoma]] | ||
- [[ | - [[Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)]] | ||
- [[ | - [[Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract]] | ||
*[[ | *[[Hepatosplenic T-cell Lymphoma]] | ||
*[[ | *[[Subcutaneous Panniculitis-Like T-cell Lymphoma]] | ||
*[[ | *[[Mycosis Fungoides]] | ||
*[[ | *[[Sézary Syndrome]] | ||
*[[ | *[[Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders]] | ||
- [[ | - [[Lymphomatoid Papulosis]] | ||
- [[ | - [[Primary Cutaneous Anaplastic Large Cell Lymphoma]] | ||
*[[ | *[[Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes]] | ||
- [[ | - [[Primary Cutaneous Gamma Delta T-cell Lymphoma]] | ||
- [[ | - [[Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma]] | ||
- [[ | - [[Primary Cutaneous Acral CD8+ T-cell Lymphoma]] | ||
- [[ | - [[Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder]] | ||
*[[ | *[[Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)]] | ||
*[[ | *[[Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin]] | ||
- [[ | - [[Angioimmunoblastic T-cell Lymphoma]] | ||
- [[ | - [[Follicular T-cell Lymphoma]] | ||
- [[ | - [[Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype]] | ||
*[[ | *[[Anaplastic Large Cell Lymphoma, ALK-Positive]] | ||
*[[ | *[[Anaplastic Large Cell Lymphoma, ALK-Negative]] | ||
*[[ | *[[Breast Implant-Associated Anaplastic Large Cell Lymphoma]] | ||
==Hodgkin Lymphomas ([[ | ==Hodgkin Lymphomas ([[Hodgkin Lymphomas|Overview Page Link]])== | ||
*[[ | *[[Nodular Lymphocyte Predominant Hodgkin Lymphoma]] | ||
*[[ | *[[Classic Hodgkin Lymphoma]] | ||
- [[ | - [[Nodular Sclerosis Classic Hodgkin Lymphoma]] | ||
- [[ | - [[Lymphocyte-Rich Classic Hodgkin Lymphoma]] | ||
- [[ | - [[Mixed Cellularity Classic Hodgkin Lymphoma]] | ||
- [[ | - [[Lymphocyte-Depleted Classic Hodgkin Lymphoma]] | ||
==Immunodeficiency-Associated Lymphoproliferative Disorders ([[ | ==Immunodeficiency-Associated Lymphoproliferative Disorders ([[Immunodeficiency-Associated Lymphoproliferative Disorders|Overview Page Link]])== | ||
*[[ | *[[Lymphomas Associated with HIV Infection]] | ||
*[[ | *[[Post-Transplant Lymphoproliferative Disorders]] | ||
- [[ | - [[Non-Destructive Post-Transplant Lymphoproliferative Disorders]] | ||
- [[ | - [[Polymorphic Post-Transplant Lymphoproliferative Disorders]] | ||
- [[ | - [[Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)]] | ||
- [[ | - [[Monomorphic B-cell PTLD]] | ||
- [[ | - [[Monomorphic T/NK-cell PTLD]] | ||
- [[ | - [[Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder]] | ||
*[[ | *[[Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders]] | ||
==Histiocytic and Dendritic Cell Neoplasms ([[ | ==Histiocytic and Dendritic Cell Neoplasms ([[Histiocytic and Dendritic Cell Neoplasms|Overview Page Link]])== | ||
*[[ | *[[Histiocytic Sarcoma]] | ||
*[[ | *[[Tumors Derived From Langerhans Cells]] | ||
- [[ | - [[Langerhans Cell Histiocytosis]] | ||
- [[ | - [[Langerhans Cell Sarcoma]] | ||
*[[ | *[[Indeterminate Dendritic Cell Tumour]] | ||
*[[ | *[[Interdigitating Dendritic Cell Sarcoma]] | ||
*[[ | *[[Follicular Dendritic Cell Sarcoma]] | ||
- [[ | - [[Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma]] | ||
*[[ | *[[Fibroblastic Reticular Cell Tumor]] | ||
*[[ | *[[Disseminated Juvenile Xanthogranuloma]] | ||
*[[ | *[[Erdheim-Chester Disease]] | ||
==Notes== | ==Notes== | ||
<nowiki>*</nowiki>The hierarchical tumour classification structure displayed on this page is reproduced from the [https://tumourclassification.iarc.who.int/welcome/ WHO Classification of Tumours] with permission from the copyright holder, ©International Agency for Research on Cancer. | <nowiki>*</nowiki>The hierarchical tumour classification structure displayed on this page is reproduced from the [https://tumourclassification.iarc.who.int/welcome/ WHO Classification of Tumours] with permission from the copyright holder, ©International Agency for Research on Cancer. | ||